Some drugmakers are taking the unusual step of sending more medicines by air to the U.S., two executives and two logistics ...
Concerns about potential pharma tariffs began before Trump took office after he repeatedly threatened a 25% tariff.
Reports suggested that promoter Tau Investment Holdings Pte was likely to sell a 10.2 per cent stake in the company through ...
Sources said the offer price was set at ₹1,625 per share, a 4.9% discount to its last closing price. The total deal size was ...
The pharmaceutical and cosmetics industries have gone to the EU's court to challenge a directive that requires them to ...
Armas Pharmaceuticals, a leading provider of high-quality pharmaceutical products, is pleased to announce the reintroduction of Lidocaine Jelly 2% 30mL to the U.S. market. This key product has been ...
Warns that Indian pharmaceutical products could become more expensive in the US, reducing their competitiveness in one of the ...
Global investment firm KKR has divested a 5.8% stake in JB Chemicals & Pharmaceuticals for Rs 1,460 crore through open market ...
Hetero Group founder, B Parthasaradhi Reddy, warns of potential US reciprocal tariffs on Indian pharmaceuticals, which could ...
Meanwhile, the spirits industry – Irish whiskey, cream liqueurs and gins – were shook by threats from Trump of a 200 per cent ...
9hon MSN
Shares of JB Chemicals and Pharmaceuticals fell over 7% after KKR’s block deal, offloading a 5.78% stake. Despite a robust ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results